Yaned Gaitan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yaned Gaitan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Cathleen M. Lutz
Rare Disease Translational Center, The Jackson Laboratory, Bar Harbor, USA
2 shared publications - Kathy J. Snow
The Jackson Laboratory , 600 Main Street, Bar Harbor, ME 04609
2 shared publications - Stephen A. Murray
The Jackson Laboratory
2 shared publications Alejandro Chavez
Department of Pediatrics, University of California San Diego, La Jolla, CA 92037
1 shared publication- Benjamin E. Low
The Jackson Laboratory, Bar Harbor, ME, USA, 04609
1 shared publication - Caleb Heffner
The Jackson Laboratory, Bar Harbor, ME, USA
1 shared publication
Latest Publications
- Open Access
Novel mouse reporter models for the detection of genome editing events in vivo
With the expansion of therapeutic gene editing technology, small animal models provide essential platforms to evaluate the function of these new approaches in vivo . As part of the Somatic Cell Genome Editing (SCGE) Consortium, we developed next-generation murine reporters that overcome current model limitations and broaden detectable in vivo editing outcomes. These include two mouse models built on the “traffic light” reporter concept. This system enables fluorescent detection of both gene repair (green) and CRISPR-generated indels (red) events following editing by a single guide and either dsDNA or single-stranded oligonucleotide donor. We also generated a third reporter model that efficiently detects A-base editor activity. Reporters were validated in cultured embryos, via germline editing, and through activation in vivo by AAV transduction or direct ribonucleoprotein delivery. Together, these new models provide a valuable resource for improved detection of genome editing events in vivo .
Open AccessNovel mouse reporter models for the detection of genome editing events in vivo
With the expansion of therapeutic gene editing technology, small animal models provide essential platforms to evaluate the function of these new approaches in vivo . As part of the Somatic Cell Genome Editing (SCGE) Consortium, we developed next-generation murine reporters that overcome current model limitations and broaden detectable in vivo editing outcomes. These include two mouse models built on the “traffic light” reporter concept. This system enables fluorescent detection of both gene repair (green) and CRISPR-generated indels (red) events following editing by a single guide and either dsDNA or single-stranded oligonucleotide donor. We also generated a third reporter model that efficiently detects A-base editor activity. Reporters were validated in cultured embryos, via germline editing, and through activation in vivo by AAV transduction or direct ribonucleoprotein delivery. Together, these new models provide a valuable resource for improved detection of genome editing events in vivo .
- Open Access
- 14 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (34)
Focused ultrasound–mediated brain genome editing
Gene editing in the brain has been challenging because of the restricted transport imposed by the blood–brain barrier (BBB). Current approaches mainly rely on local injection to bypass the BBB. However, such administration is highly invasive and not amenable to treating certain delicate regions of the brain. We demonstrate a safe and effective gene editing technique by using focused ultrasound (FUS) to transiently open the BBB for the transport of intravenously delivered CRISPR/Cas9 machinery to the brain.
- 14 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (34)
Open AccessFocused ultrasound–mediated brain genome editing
Gene editing in the brain has been challenging because of the restricted transport imposed by the blood–brain barrier (BBB). Current approaches mainly rely on local injection to bypass the BBB. However, such administration is highly invasive and not amenable to treating certain delicate regions of the brain. We demonstrate a safe and effective gene editing technique by using focused ultrasound (FUS) to transiently open the BBB for the transport of intravenously delivered CRISPR/Cas9 machinery to the brain.